Journal of Renal Medicine : Citations & Metrics Report

Articles published in Journal of Renal Medicine have been cited by esteemed scholars and scientists all around the world. Journal of Renal Medicine has got h-index 5, which means every article in Journal of Renal Medicine has got 5 average citations.

Following are the list of articles that have cited the articles published in Journal of Renal Medicine.

  2023 2022 2021 2020 2019

Total published articles

0 15 14 6 1

Conference proceedings

0 0 0 0 0

Citations received as per Google Scholar, other indexing platforms and portals

1 15 5 6 9
Journal total citations count 55
Journal impact factor 0.85
Journal 5 years impact factor 1.76
Journal cite score 1.78
Journal h-index 5
Journal h-index since 2019 5
image

Yeter, H. H., Akcay, O. F., Ronco, C., & Derici, U. (2020). Automated remote monitoring for peritoneal dialysis and its impact on blood pressure. Cardiorenal medicine, 10(3), 198-208.

  View at Publisher | View at Google Scholar | View at Indexing
image

Pereira, C. V., & Leite, I. C. G. (2019). Health-related quality of life of patients receiving hemodialysis therapy. Acta Paulista de Enfermagem, 32, 267-274.

  View at Publisher | View at Google Scholar | View at Indexing
image

Rai, Dipsika, Aporn Deenan, and Nisakorn Krungkraipetch. "Factors influencing self-management of end-stage renal disease (ESRD) patients undergoing hemodialysis in Bhutan." Thai Pharmaceutical and Health Science Journal-?????? ??? ??????????? ??? ???????? ?????? 14.1 (2019): 26-34.

  View at Publisher | View at Google Scholar | View at Indexing
image

Pereira, Cláudio Vitorino, and Isabel Cristina Gonçalves Leite. "Qualidade de vida relacionada à saúde de pacientes em terapêutica hemodialítica." Acta Paulista de Enfermagem 32 (2019): 267-274.

  View at Publisher | View at Google Scholar | View at Indexing
image

Efremova, E. V., Shutov, A. M., & Borodulina, E. O. (2015). Motivation for treatment in patients with chronic cardiorenal syndrome. Terapevticheskii arkhiv, 87(12), 13-17.

  View at Publisher | View at Google Scholar | View at Indexing
image

Moktan, Satchina, Sirirat Leelacharas, and Wonnapha Prapaipanich. "Knowledge, Self-Efficacy, Self-Management Behavior of the Patients With Predialysis Chronic Kidney Disease." Ramathibodi Medical Journal 42.2 (2019): 38-48.

  View at Publisher | View at Google Scholar | View at Indexing
image

Moktan, Satchina, Sirirat Leelacharas, and Wonnapha Prapaipanich. "Knowledge, Self-Efficacy, Self-Management Behavior of the Patients With Predialysis Chronic Kidney Disease." Ramathibodi Medical Journal 42.2 (2019): 38-48.

  View at Publisher | View at Google Scholar | View at Indexing
image

In the general population, the prevalence of moderate and severe chronic kidney disease (CKD) is usually below 5% but this figure is often higher in specific groups of patients such as those with type 2 diabetes. Patients with advanced CKD (CKD stage 3b and 4) are at high or very high cardiovascular risk, and their risk of progressing towards end-stage kidney disease (CKD stage 5) and the need of renal replacement therapy are elevated. Hypertension is a major cause of poor cardiovascular and renal outcomes in severe CKD. Therefore, an adequate control of blood pressure (BP) is mandatory. However, normalizing BP is often challenging in these patients because the clinical management of hypertension in advanced CKD is not well defined and rarely supported by large randomized controlled trials. In the present review, we discuss the characteristics of hypertension in advanced CKD, excluding dialysis, and its management integrating data from recent clinical studies and a pragmatic approach enriched by a long-standing clinical experience.

  View at Publisher | View at Google Scholar | View at Indexing
image

Iseri, Ken, et al. "Elimination of intravenous alendronate by hemodialysis: a kinetic study." Hemodialysis International 23.4 (2019): 466-471.

  View at Publisher | View at Google Scholar | View at Indexing
image

Widén, Julia, et al. "Cost-Effectiveness Analysis of Patiromer in Combination with Renin–Angiotensin–Aldosterone System Inhibitors for Chronic Kidney Disease in Sweden." PharmacoEconomics 38.7 (2020): 747-764.

  View at Publisher | View at Google Scholar | View at Indexing
image

Ahmed, Sofia B., and Sandra M. Dumanski. "Why do patients with well-controlled vascular risk factors develop progressive chronic kidney disease?." Canadian Journal of Cardiology 35.9 (2019): 1170-1180.

  View at Publisher | View at Google Scholar | View at Indexing
image

Arenas, Maria Dolores, et al. "Control of hyperparathyroidism with the intravenous calcimimetic etelcalcetide in dialysis patients adherent and non-adherent to oral calcimimetics." Clinical Kidney Journal 14.3 (2021): 840-846.

  View at Publisher | View at Google Scholar | View at Indexing
image

Hain, Debra, Holly Tomlin, and Cristian Gibson. "Administration of Etelcalcetide for the Treatment of Secondary Hyperparathyroidism in Patients with CKD-MBD on Hemodialysis: A Nephrology Nursing Perspective." Nephrology Nursing Journal 46.3 (2019).

  View at Publisher | View at Google Scholar | View at Indexing
image

Kim, Seok-hyung, et al. "New oral spherical carbon adsorbent effectively reduces serum indoxyl sulfate levels in moderate to advanced chronic kidney disease patients: a multicenter, prospective, open-label study." BMC nephrology 21.1 (2020): 1-10.

  View at Publisher | View at Google Scholar | View at Indexing
image

Kim, Seok-hyung, et al. "New oral spherical carbon adsorbent effectively reduces serum indoxyl sulfate levels in moderate to advanced chronic kidney disease patients: a multicenter, prospective, open-label study." BMC nephrology 21.1 (2020): 1-10.

  View at Publisher | View at Google Scholar | View at Indexing
image

Roggeri, Alessandro, et al. "Cinacalcet adherence in dialysis patients with secondary hyperparathyroidism in Lombardy Region: clinical implications and costs." Drugs in context 9 (2020).

  View at Publisher | View at Google Scholar | View at Indexing
image

Nolin, Thomas D., and Mark A. Perazella. "Introduction to nephropharmacology for the clinician: A new CJASN series." Clinical Journal of the American Society of Nephrology 13.7 (2018): 1083-1084.

  View at Publisher | View at Google Scholar | View at Indexing
image

Muller, Clotilde, et al. "Observance et lecture des notices, quel lien et quels médias? Résultats d’une population avec maladie rénale chronique." Néphrologie & Thérapeutique 12.6 (2016): 443-447.

  View at Publisher | View at Google Scholar | View at Indexing
image

Ariceta, Gema, et al. "Transición coordinada del paciente con cistinosis desde la medicina pediátrica a la medicina del adulto." nefrologia 36.6 (2016): 616-630.

  View at Publisher | View at Google Scholar | View at Indexing
image

Dasgupta, Indranil, and Carmine Zoccali. "Is the KDIGO Systolic Blood Pressure Target< 120 mm Hg for Chronic Kidney Disease Appropriate in Routine Clinical Practice?." Hypertension (2021): HYPERTENSIONAHA-121.

  View at Publisher | View at Google Scholar | View at Indexing